| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.8 |